Page last updated: 2024-08-23

eniluracil and doxifluridine

eniluracil has been researched along with doxifluridine in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eda, H; Endoh, M; Hattori, K; Horii, I; Ishikawa, T; Ishitsuka, H; Kawashima, A; Kohchi, Y; Miwa, M; Oikawa, N; Shimma, N; Suda, H; Tanimura, H; Ura, M	1
González Barón, M	1
Britten, C; Hammond, L; Hidalgo, M; Rothenberg, ML; Sharma, A; Sharma, S; Siu, L; Villalona-Calero, M; Weiss, GR	1
Chionh, F; Lau, D; Price, T; Tebbutt, N; Yeung, Y	1

Reviews

3 review(s) available for eniluracil and doxifluridine

Article	Year
[Oral fluoropyrimidines in oncology]. Anales de la Real Academia Nacional de Medicina, 1998, Volume: 115, Issue:3 Topics: Administration, Oral; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Female; Floxuridine; Fluorouracil; Humans; Leucovorin; Male; Neoplasm Recurrence, Local; Neoplasms; Tegafur; Time Factors; Uracil	1998
New anticancer agents. Cancer chemotherapy and biological response modifiers, 1999, Volume: 18 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cyclin-Dependent Kinases; DNA; Floxuridine; Humans; Microtubules; Organoplatinum Compounds; Signal Transduction; Thymidylate Synthase; Uracil	1999
Oral versus intravenous fluoropyrimidines for colorectal cancer. The Cochrane database of systematic reviews, 2017, Jul-28, Volume: 7 Topics: Administration, Oral; Adult; Antineoplastic Agents; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Floxuridine; Fluorouracil; Humans; Injections, Intravenous; Irinotecan; Male; Neoadjuvant Therapy; Organoplatinum Compounds; Palliative Care; Pyridines; Pyrimidines; Randomized Controlled Trials as Topic; Tegafur; Uracil	2017

Other Studies

1 other study(ies) available for eniluracil and doxifluridine

Article	Year
Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine. Bioorganic & medicinal chemistry letters, 2003, Mar-10, Volume: 13, Issue:5 Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Non-Small-Cell Lung; Cytidine Deaminase; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Design; Drug Stability; Esterases; Female; Fluorouracil; Humans; Lung Neoplasms; Mice; Oxidoreductases; Prodrugs; Thymidine Phosphorylase; Tissue Distribution; Uracil; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays	2003

Article

Year

Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine.

Bioorganic & medicinal chemistry letters, 2003, Mar-10, Volume: 13, Issue:5

Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Non-Small-Cell Lung; Cytidine Deaminase; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Design; Drug Stability; Esterases; Female; Fluorouracil; Humans; Lung Neoplasms; Mice; Oxidoreductases; Prodrugs; Thymidine Phosphorylase; Tissue Distribution; Uracil; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays

2003